Adicet Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Adicet Bio, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue0.000.7124.999.7317.90
Cost of Revenue0.000.000.000.000.00
Gross Profit0.000.710.709.7317.90
Operating Expenses
Research & Development99.32106.0471.2548.9434.33
Selling, General & Administrative28.2926.5326.3022.2222.76
Operating Expenses127.62132.5897.5471.1657.09
Operating Income-127.62-132.58-72.55-61.43-39.19
Other Income/Expense
Interest Income10.719.983.760.090.79
Interest Expense0.00-0.030.08-0.18-0.13
Other Income/Expense-0.22-0.57-0.920.610.95
Income
Income Before Tax-117.12-142.66-69.79-62.12-39.49
Income Tax Expense0.000.000.00-0.13-2.82
Net Income-117.12-142.66-69.79-62.00-36.68
Net Income - Continuous Operations-117.12-142.66-69.79-62.000.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-110.65-126.48-67.14-60.41-38.13
EBIT-117.12-132.58-69.71-61.95-39.36
Depreciation & Amortization6.476.102.581.501.20
Earnings Per Share
Basic EPS-21.00-53.00-27.00-2.00-5.00
Diluted EPS-21.00-53.00-27.00-2.00-5.00
Basic Shares Outstanding5.492.692.5730.957.32
Diluted Shares Outstanding5.492.692.571.937.32